Trial Profile
A Pilot Study of Vincristine Sulfate Liposome Injection (Marqibo) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapse of Acute Lymphoblastic Leukemia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 19 Mar 2024
Price :
$35
*
At a glance
- Drugs Vincristine (Primary) ; Asparaginase; Dexamethasone; Mercaptopurine; Methotrexate; Methotrexate; Mitoxantrone; Pegaspargase
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 14 Dec 2021 Results from Cohort A (n=10) ealuating toxicities and feasibilities, presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 15 Apr 2020 Planned End Date changed from 1 May 2021 to 31 Dec 2022.
- 15 Apr 2020 Planned primary completion date changed from 31 Aug 2020 to 31 Aug 2021.